Related Experiment Video
Updated: Jun 27, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
Standard operating procedures for serum and plasma collection: early detection research network consensus statement
Melissa K Tuck1, Daniel W Chan, David Chia
1Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-0725, USA. mtuck@umich.edu
This article outlines standard operating procedures for collecting and handling serum and plasma specimens. These procedures are essential for biomarker discovery and validation. The Early Detection Research Network formed a working group to develop these SOPs. The goal is to reduce variability in specimen handling, which can affect analytical results. The SOPs cover collection timing, centrifugation, storage, and handling. They aim to improve reliability in biomarker studies. The SOPs are designed to support translational research goals. These guidelines help ensure consistent specimen quality for clinical research.
Area of Science:
- Clinical research methodology
- Biomarker discovery
- Translational medicine
Background:
High-quality specimens are vital for biomarker discovery. Standardized collection methods reduce variability. Prior research has shown that inconsistent handling affects analytical outcomes. Multiplex methods amplify these effects. No prior work had resolved optimal specimen handling for translational goals. This gap motivated the formation of the SOPIWG. The EDRN aims to detect diseases earlier through reliable biomarkers. Standard operating procedures must align with evolving analytic techniques.
Purpose Of The Study:
The study aimed to define SOPs for serum and plasma collection. These procedures are essential for biomarker discovery and validation. The working group sought consensus across EDRN. The goal is to minimize bias and confounding factors. SOPs must be defined prospectively in trial design. Small handling differences impact reliability. Multiplex methods require standardized approaches. The EDRN needs consistent specimen handling for translational research.
Main Methods:
The working group included EDRN members across disciplines. They reviewed existing specimen handling practices. They evaluated how collection affects biomarker reliability. SOPs were drafted based on consensus. The focus was on serum and plasma. Processing steps were standardized. Handling and storage protocols were outlined. The SOPs aim to ensure reproducibility in biomarker studies.
Main Results:
The SOPs specify collection timing and temperature. They outline centrifugation speed and duration. Storage conditions include temperature and duration. The SOPs address aliquoting and labeling. They recommend avoiding repeated freeze-thaw cycles. Multiplex methods require specific handling. The SOPs emphasize minimizing pre-analytical variability. These steps aim to improve analytical reliability.
Conclusions:
The SOPs provide a framework for serum and plasma handling. They aim to reduce variability in biomarker studies. The working group emphasized standardized procedures. Prospective SOPs are essential for clinical trial design. Multiplex methods require careful handling. The SOPs address centrifugation and storage. They aim to improve reproducibility in translational research. These guidelines support EDRN’s biomarker discovery goals.
Frequently Asked Questions
The SOPs aim to standardize specimen handling to improve biomarker study reliability.
The working group formed a consensus on collection, processing, and storage methods.
To minimize variability in plasma and serum separation for biomarker analysis.
Storage conditions are outlined to prevent degradation and maintain specimen quality.
The SOPs recommend avoiding repeated freeze-thaw cycles to preserve biomarker integrity.
Multiplex methods require precise handling to ensure reliable biomarker detection.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021